Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection. The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the a
![Drug Goes From $13.50 a Tablet to $750, Overnight (Published 2015)](https://cdn-ak-scissors.b.st-hatena.com/image/square/5a788ea338a04913565b8e7c32bd3d90495677d9/height=288;version=1;width=512/https%3A%2F%2Fstatic01.nyt.com%2Fimages%2F2015%2F09%2F21%2Fbusiness%2F21drugpricespix%2F21drugpricespix-facebookJumbo.jpg%3Fyear%3D2015%26h%3D311%26w%3D594%26s%3D4b4e3c73beeda50ae39813ea23a1b74fe990bab186370b753a56e5999ec1ffe6%26k%3DZQJBKqZ0VN)